| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 09/15/2010 | CN101185727B Traditional Chinese medicine preparation containing ginseng and pilose antler capable of nourishing heart and nourishing kidney |
| 09/14/2010 | US7795428 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 09/14/2010 | US7795302 use of topical formulation for treating rosacea containing a combination of an antimicrobial and at least one of non-retinoid inhibitor of one of nuclear factor-k-beta, AP-1 protein, matrix metalloproteinases, CD14 |
| 09/14/2010 | US7795301 preventing myxoviruses infection using 3-(acetylamino)-2-{3-(acetylamino)-4-{[amino(imino)methyl]amino}-6-carboxy-3,4-dihydro-2H-pyran-2-yl)-1-[1,2-dihydroxyethyl]-19,20-dihydroxy-3,16-dioxo-2,17-dioxa-4,15-diazaicos-1-yl}-4-{[amino(imino)methyl]-amino}-3,4-dihydro-2H--pyran-6-carboxylic acid; viricides |
| 09/14/2010 | US7795293 3′-[(2Z)-[1-(3,4-dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2′-hydroxy-[1,1′-biphenyl]-3-carboxylic acid bis-(monoethanolamine) |
| 09/14/2010 | US7795281 (R)-2-amino-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(1-diphenylmethylazetidin-3-yl) ester 5-isopropyl ester; calcium antagonistic action, antihypertensive action, vascular dilatory action, cardiac protective action, anti-arteriosclerotic action, diuretic action |
| 09/14/2010 | US7795267 G protein-coupled receptor antagonists such as phenyl tetrahydro-3-oxo-1,1-diphenyl-3H-oxazolo[3,4-a]pyrazine-7(1H)-carboxylate, used for treating cancer, Alzheimer's disease, dementia, eating disorder, hypertension, glandular disorders, diabetes and hyperlipemia |
| 09/14/2010 | US7795229 beta-lactam compounds having a C-glycoside in the molecule, in combination with a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor selected from atorvastatin and rosuvastatin; synergistic |
| 09/14/2010 | US7795214 polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor; induce DNA synthesis, protect from liver damage from acetaminophen; gene therapy; promote cell growth angiogenesis, treatment of cardiovascular, hepatic, musculoskeletal, neuronal diseases |
| 09/14/2010 | US7795023 Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell |
| 09/14/2010 | US7794995 use of several sequential steps, including subcellular fractionation to isolate a plasma membrane fraction and the use of gel filtration or chromatography that separates molecules according to their size or affinity; drug screening |
| 09/14/2010 | US7794975 Polypeptide ESDN, polynucleotides encoding the polypeptide, and utility of the polypeptide |
| 09/14/2010 | US7794748 Stable oral solid drug composition |
| 09/14/2010 | US7794739 composition for applying to skin containing at least one purine nucleic acid-related substance chosen from adenosine monophosphate and salt thereof, at least one pyrimidine nucleic acid-related substance chosen from uridine monophosphate and salt thereof, and at least one additive; anti-aging, anti-acne |
| 09/14/2010 | US7794715 T-cell immune response cDNA 7 (TIRC7) antagonist; rheumatoid arthritis; comprising all three complementarity determining regions (CDRs) of the VH and all three complementarity determining regions (CDRs) of the VL variable regions |
| 09/14/2010 | CA2479353C N-substituted benzothiophenesulfonamide derivative |
| 09/14/2010 | CA2458744C Anticancer agents and preparation method of the same |
| 09/14/2010 | CA2441501C Rho-kinase inhibitors |
| 09/14/2010 | CA2432009C Pharmaceutical preparations comprising a salt of an antibiotic and an antiphlogistic and use thereof |
| 09/14/2010 | CA2422805C Retinoids for the treatment of emphysema |
| 09/14/2010 | CA2416990C Nutritional composition |
| 09/14/2010 | CA2410965C Method of stimulating hair growth |
| 09/14/2010 | CA2409715C .beta.-carboline derivatives useful as inhibitors of phosphodiesterase |
| 09/14/2010 | CA2401757C Novel fatty acid analogues |
| 09/14/2010 | CA2262014C Adipogenic differentiation of human mesenchymal stem cells |
| 09/14/2010 | CA2261666C Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxiethyl)-rapamycin |
| 09/14/2010 | CA2260291C Antagonists of intestinotrophic glp-2 peptides |
| 09/14/2010 | CA2222217C Use of fibroblast growth factors mutants to stimulate bone growth |
| 09/10/2010 | WO2010101248A1 Cell proliferation inhibitor and method for screening same |
| 09/10/2010 | WO2010101247A1 Cyclohexane derivative having npy y5 receptor antagonism |
| 09/10/2010 | WO2010101246A1 Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
| 09/10/2010 | WO2010101230A1 Quinoxaline compounds |
| 09/10/2010 | WO2010101192A1 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases |
| 09/10/2010 | WO2010101164A1 Pyridine derivative |
| 09/10/2010 | WO2010101128A1 Amide compound |
| 09/10/2010 | WO2010101061A1 Nucleoside-type antibiotic derivative |
| 09/10/2010 | WO2010100686A1 Combination use of cholestanol derivative |
| 09/10/2010 | WO2010100060A2 Method for increasing endogenous plasmalogen levels in mammals |
| 09/10/2010 | WO2010083439A3 New stable formulations of recombinant human albumin-human granulocyte colony stimulating factor fusion protein |
| 09/10/2010 | CA2754457A1 Quinoxaline compounds |
| 09/10/2010 | CA2754446A1 Pyridine derivative |
| 09/10/2010 | CA2754075A1 Cholestanol derivative for combined use |
| 09/09/2010 | US20100228018 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATING CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/09/2010 | US20100227912 RNA INTERFERENCE MEDIATED INHIBITION OF MYOSTATIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 09/09/2010 | US20100227896 Use of vitamin pp compounds |
| 09/09/2010 | US20100227871 Nicotinic receptor agonists for the treatment of inflammatory diseases |
| 09/09/2010 | US20100227864 5-membered heterocyclic derivative and use thereof for medical purposes |
| 09/09/2010 | US20100227820 Effect of Porcine Sheath Proteins on the Regeneration Activity of Periodontal Ligament |
| 09/09/2010 | US20100227819 Serum-Free Cell Culture Medium for Mammalian Cells |
| 09/09/2010 | US20100227814 Inhibitors of gsk-3 and crystal structures of gsk-3beta protein and protein complexes |
| 09/09/2010 | US20100227812 Method of supplementing the diet and ameliorating oxidative stress |
| 09/09/2010 | US20100227802 Methods and materials relating to PAQR polypeptides and polynucleotides |
| 09/09/2010 | US20100227354 Autoimmune Conditions and NADPH Oxidase Defects |
| 09/09/2010 | US20100227007 Dietary supplements containing extracts of nelumbo and processes of using same |
| 09/09/2010 | US20100226994 Granule, tablet and methods for producing the same |
| 09/09/2010 | US20100226982 Stabilized Active Ingredient Composition |
| 09/09/2010 | US20100226960 Natural biodegradable matrices and uses thereof |
| 09/09/2010 | US20100226947 Articles of manufacture releasing an active ingredient |
| 09/09/2010 | US20100226944 Process for the preparation of controlled-release solid formulations containing oxcarbazepine, and formulations obtainable by said process |
| 09/09/2010 | US20100226935 System and method for assessing traditional medicines |
| 09/09/2010 | US20100226927 Selective immunodepletion of endogenous stem cell niche for engraftment |
| 09/09/2010 | US20100226925 Homogeneous Antibody Populations |
| 09/09/2010 | US20100226921 Methods for treating obesity using Fibroblast Growth Factor-Like Polypeptides |
| 09/09/2010 | US20100226870 Use of creatine or creatine compounds for skin preservation |
| 09/09/2010 | US20100226861 Topical composition detection |
| 09/09/2010 | US20100226855 Rate-Controlled Oral Dosage Formulations |
| 09/09/2010 | DE10336768B4 Medikament zur Verbesserung der Sauerstoffutilation Medication to improve Sauerstoffutilation |
| 09/09/2010 | DE102009001334A1 Multiple capsule, useful for oral administration of gastric fluid sensitive substance and treating e.g. inflammatory diseases e.g. pure arthritis in human, dog or cat, comprises two capsules nested within each other on its cylindrical part |
| 09/08/2010 | EP2226632A1 Method for screening of cell-protecting agent |
| 09/08/2010 | EP2226324A1 Beta-amino tetrahydroimidazo(1,2-a)pyrazines and tetrahydrotriazolo(4,3-a)pyrazines for use in the treatment of diabetes type ii |
| 09/08/2010 | EP2226318A2 Dye-Azide compounds for dual photherapy |
| 09/08/2010 | EP2226315A1 2-aminoquinazoline derivative |
| 09/08/2010 | EP2226083A1 Drug delivery system |
| 09/08/2010 | EP2226081A1 Peptide vaccine using mimic molecule of amyloid beta-peptide |
| 09/08/2010 | EP2226075A1 Material for preventing tissue adhesion and material for preventing joint contracture |
| 09/08/2010 | EP2224927A1 Pterin analog for treating bh4 responsive condition |
| 09/08/2010 | EP1901755B1 New pharmaceutical compositions containing hyaluronic acid or its derivatives and collagenase for the topical treatment of wounds, burns and ulcers |
| 09/08/2010 | EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 09/08/2010 | EP1478624B1 Chemical compounds |
| 09/08/2010 | EP1399190B1 Pharmaceutical compositions comprising low-solubility and acid-sensitive drugs and neutralized acidic polymers |
| 09/08/2010 | EP1388340B1 Compositions for transmucosal administration containing coenzyme q as the active ingredient |
| 09/08/2010 | EP1320531B1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/08/2010 | EP1263759B1 Azaindoles |
| 09/08/2010 | CN1939453B Gambir plant extract and its use in preparation of target organ protective medicine |
| 09/08/2010 | CN1842341B Active fraction having anti-cancer and anti-metastic activity isolated from leaves and stems of ginseng |
| 09/08/2010 | CN1659144B Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 09/08/2010 | CN1613482B Composition for improving memory |
| 09/08/2010 | CN101827936A CDH3 peptide and medicinal agent comprising the same |
| 09/08/2010 | CN101827843A Method for producing pyrazole fused ring derivative |
| 09/08/2010 | CN101827816A Therapeutic agent for TRPV1-mediated disease |
| 09/08/2010 | CN101827594A Combination therapy for reducing side effects using cannabinoid receptor ligands |
| 09/08/2010 | CN101824435A Expression system of tilapia neuropeptide Y recombinant protein |
| 09/08/2010 | CN101824036A Salt of tetrahydroimidazo [1,5-a] pyrazine derivative, preparation method and pharmaceutical application thereof |
| 09/08/2010 | CN101824029A Tyrosine kinase irreversible inhibitor and medicine composition and application thereof |
| 09/08/2010 | CN101822834A Remedy for diabetes |
| 09/08/2010 | CN101822717A Preparation of compound Chinese herbal medicine with function of promoting growth of cryprinus carpiod |
| 09/08/2010 | CN101822671A Rabeprazde composition and preparation method thereof |
| 09/08/2010 | CN101361748B Use of ginsenoside in preparing medicine for treating infrasound impariment |
| 09/08/2010 | CN101254191B Use of quinazoline glyoxaline compounds |
| 09/08/2010 | CN101244047B Application of octacosanol in preparing medicament for preventing and controlling altitude erythrocytosis |